Lead extraction is preferred for lead revisions and system upgrades when less is more

Circulation: Arrhythmia and Electrophysiology

Volumn 3, Issue 4, 2010, Pages 413-424

  Maytin, Melanie ^a   Epstein, Laurence M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC PAIN; CLINICAL TRIAL; DEVICE INFECTION; DEVICE REMOVAL; ELECTRODE; HUMAN; LEAD EXTRACTION; MEDICAL DECISION MAKING; PATIENT SAFETY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREATMENT INDICATION; TRICUSPID VALVE; VASCULAR ACCESS; VEIN OCCLUSION; VEIN THROMBOSIS; ARTIFICIAL HEART PACEMAKER; CARDIOVERSION; DEFIBRILLATOR; EQUIPMENT DESIGN; EVIDENCE BASED MEDICINE; HEART PACING; INSTRUMENTATION; NOTE; PATIENT SELECTION; PRACTICE GUIDELINE; RISK ASSESSMENT; TREATMENT OUTCOME;

CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; ELECTRIC COUNTERSHOCK; EQUIPMENT DESIGN; EVIDENCE-BASED MEDICINE; HUMANS; PACEMAKER, ARTIFICIAL; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 77956663121     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.110.954107     Document Type: Article

References (80)

1. Hammill SC, Kremers MS, Kadish AH, Stevenson LW, Heidenreich PA, Lindsay BD, Mirro MJ, Radford MJ, McKay C, Wang Y, Lang CM, Pontzer K, Rumsfeld J, Phurrough SE, Curtis JP, Brindis RG. Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance. Heart Rhythm. 2009;6:1397-1401.
2. Maisel WH, Moynahan M, Zuckerman BD, Gross TP, Tovar OH, Tillman DB, Schultz DB. Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports. JAMA. 2006;295: 1901-1906.
3. DeFrances CJ, Lucas CA, Buie VC, Golosinskiy A. National Hospital Discharge Survey. Natl Health Stat Report. 2006;2008:1-20.
4. Borek PP, Wilkoff BL. Pacemaker and ICD leads: strategies for long-term management. J Interv Card Electrophysiol. 2008;23:59-72.
5. Agarwal SK, Kamireddy S, Nemec J, Voigt A, Saba S. Predictors of complications of endovascular chronic lead extractions from pacemakers and defibrillators: a single-operator experience. J Cardiovasc Electrophysiol. 2009;20:171-175.
6. Eckstein J, Koller MT, Zabel M, Kalusche D, Schaer BA, Osswald S, Sticherling C. Necessity for surgical revision of defibrillator leads implanted long-term: causes and management. Circulation. 2008;117: 2727-2733.
7. Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol. 2010;33: 414-419.
8. Cabell CH, Heidenreich PA, Chu VH, Moore CM, Stryjewski ME, Corey GR, Fowler VG Jr. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J. 2004;147:582-586.
9. Haqqani HM, Mond HG. The implantable cardioverter-defibrillator lead: principles, progress, and promises. Pacing Clin Electrophysiol. 2009;32: 1336-1353.
10. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115:2474-2480.
11. Dorwarth U, Frey B, Dugas M, Matis T, Fiek M, Schmoeckel M, Remp T, Durchlaub I, Gerth A, Steinbeck G, Hoffmann E. Transvenous defibrillation leads: high incidence of failure during long-term follow-up. J Cardiovasc Electrophysiol. 2003;14:38-43.
12. Ellenbogen KA, Wood MA, Shepard RK, Clemo HF, Vaughn T, Holloman K, Dow M, Leffler J, Abeyratne A, Verness D. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. J Am Coll Cardiol. 2003;41:73-80.
13. Luria D, Glikson M, Brady PA, Lexvold NY, Rasmussen MJ, Hodge DO, Chugh SS, Rea RF, Hayes DL, Hammill SC, Friedman PA. Predictors and mode of detection of transvenous lead malfunction in implantable defibrillators. Am J Cardiol. 2001;87:901-904.
14. Pakarinen S, Oikarinen L, Toivonen L. Short-term implantation-related complications of cardiac rhythm management device therapy: a retrospective single-centre 1-year survey. Europace. 2010;12:103-108.
15. Vatankulu MA, Goktekin O, Kaya MG, Ayhan S, Kucukdurmaz Z, Sutton R, Henein M. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices. Am J Cardiol. 2009;103:1280-1284.
16. Sweeney MO, Shea JB, Ellison KE. Upgrade of permanent pacemakers and single chamber implantable cardioverter defibrillators to pectoral dual chamber implantable cardioverter defibrillators: indications, surgical approach, and long-term clinical results. Pacing Clin Electrophysiol. 2002;25:1715-1723.
17. Foley PW, Muhyaldeen SA, Chalil S, Smith RE, Sanderson JE, Leyva F. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure. Europace. 2009; 11:495-501.
18. Bracke FA. Yes we can! But should we? Lead extraction for superfluous pacemaker and implanted cardioverter-defibrillator leads. Europace. 2009;11:546-547.
19. Bracke FALE, Meijer A, Van Gelder LM. Malfunction of endocardial defibrillator leads and lead extraction: where do they meet? Europace. 2002;4:19-24.
20. Bracke F, Meijer A, van Gelder B. Complications due to abandoned noninfected pacemaker leads. Pacing Clin Electrophysiol. 2002;25:1533; author reply 1533.
21. Levine PA. Should lead explantation be the practice standard when a lead needs to be replaced? Pacing Clin Electrophysiol. 2000;23:421-422.
22. Venkataraman G, Hayes DL, Strickberger SA. Does the risk-benefit analysis favor the extraction of failed, sterile pacemaker and defibrillator leads? J Cardiovasc Electrophysiol. 2009;20:1413-1415.
23. Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH III, Epstein LM, Friedman RA, Kennergren CE, Mitkowski P, Schaerf RH, Wazni OM. Transvenous lead extraction: Heart Rhythm Society Expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm. 2009;6:1085-1104.
24. Jones SO, Eckart RE, Albert CM, Epstein LM. Large, single-center, single-operator experience with transvenous lead extraction: outcomes and changing indications. Heart Rhythm. 2008;5:520-525.
25. Kennergren C, Bjurman C, Wiklund R, Gabel J. A single-centre experience of over one thousand lead extractions. Europace. 2009;11: 612-617.
26. Xu W, Moore HJ, Karasik PE, Franz MR, Singh SN, Fletcher RD. Management strategies when implanted cardioverter defibrillator leads fail: survey findings. Pacing Clin Electrophysiol. 2009;32:1130-1141.
27. Silvetti MS, Drago F. Outcome of young patients with abandoned, nonfunctional endocardial leads. Pacing Clin Electrophysiol. 2008;31: 473-479.
28. Madigan NP, Curtis JJ, Sanfelippo JF, Murphy TJ. Difficulty of extraction of chronically implanted tined ventricular endocardial leads. J Am Coll Cardiol. 1984;3:724-731.
29. Lee ME, Chaux A, Matloff JM. Avulsion of a tricuspid valve leaflet during traction on an infected, entrapped endocardial pacemaker electrode: the role of electrode design. J Thorac Cardiovasc Surg. 1977;74: 433-435.
30. Rettig G, Doenecke P, Sen S, Volkmer I, Bette L. Complications with retained transvenous pacemaker electrodes. Am Heart J. 1979;98: 587-594.
31. Bongiorni MG, Soldati E, Zucchelli G, Di Cori A, Segreti L, De Lucia R, Solarino G, Balbarini A, Marzilli M, Mariani M. Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leads. Eur Heart J. 2008;29:2886-2893.
32. Wazni O, Epstein LM, Carrillo RG, Love C, Adler SW, Riggio DW, Karim SS, Bashir J, Greenspon AJ, Dimarco JP, Cooper JM, Onufer JR, Ellenbogen KA, Kutalek SP, Dentry-Mabry S, Ervin CM, Wilkoff BL. Lead Extraction in the Contemporary Setting: the LExICon Study: an observational retrospective study of consecutive laser lead extractions. J Am Coll Cardiol. 2010;55:579-586.
33. Bracke FA, Meijer A, van Gelder LM. Pacemaker lead complications: when is extraction appropriate and what can we learn from published data? Heart. 2001;85:254-259.
34. Glikson M, Suleiman M, Luria DM, Martin ML, Hodge DO, Shen WK, Bradley DJ, Munger TM, Rea RF, Hayes DL, Hammill SC, Friedman PA. Do abandoned leads pose risk to implantable cardioverter-defibrillator patients? Heart Rhythm. 2009;6:65-68.
35. Hauser RG, Katsiyiannis WT, Gornick CC, Almquist AK, Kallinen LM. Deaths and cardiovascular injuries due to device-assisted implantable cardioverter-defibrillator and pacemaker lead extraction. Europace. 2010; 12:395-401.
36. Wilkoff BL, Byrd CL, Love CJ, Hayes DL, Sellers TD, Schaerf R, Parsonnet V, Epstein LM, Sorrentino RA, Reiser C. Pacemaker lead extraction with the laser sheath: results of the pacing lead extraction with the excimer sheath (PLEXES) trial. J Am Coll Cardiol. 1999;33: 1671-1676.
37. Byrd CL, Wilkoff BL, Love CJ, Sellers TD, Turk KT, Reeves R, Young R, Crevey B, Kutalek SP, Freedman R, Friedman R, Trantham J, Watts M, Schutzman J, Oren J, Wilson J, Gold F, Fearnot NE, Van Zandt HJ. Intravascular extraction of problematic or infected permanent pacemaker leads: 1994-1996. U.S. Extraction Database, MED Institute. Pacing Clin Electrophysiol. 1999;22:1348-1357.
38. Epstein LM, Byrd CL, Wilkoff BL, Love CJ, Sellers TD, Hayes DL, Reiser C. Initial experience with larger laser sheaths for the removal of transvenous pacemaker and implantable defibrillator leads. Circulation. 1999;100:516-525.
39. Smith HJ, Fearnot NE, Byrd CL, Wilkoff BL, Love CJ, Sellers TD. Five-years experience with intravascular lead extraction. U.S. Lead Extraction Database. Pacing Clin Electrophysiol. 1994;17:2016-2020.
40. Korley VJ, Hallet N, Daoust M, Epstein LM. A novel indication for transvenous lead extraction: upgrading implantable cardioverter defibrillator systems. J Interv Card Electrophysiol. 2000;4:523-528.
41. Bracke FA, van Gelder LM, Sreeram N, Meijer A. Exchange of pacing or defibrillator leads following laser sheath extraction of non-functional leads in patients with ipsilateral obstructed venous access. Heart. 2000; 83:E12.
42. Gula LJ, Ames A, Woodburn A, Matkins J, McCormick M, Bell J, Sink D, McConville J, Epstein LM. Central venous occlusion is not an obstacle to device upgrade with the assistance of laser extraction. Pacing Clin Electrophysiol. 2005;28:661-666.
43. Le Franc P, Klug D, Jarwe M, Delfaut P, Lacroix D, Kouakam C, Kacet S. Extraction and reimplantation of defibrillation leads through a thrombotic subclavian vein. Pacing Clin Electrophysiol. 1999;22: 977-978.
44. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Natale A, Packer D, Skanes A, Ambrogi F, Biganzoli E. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:32-38.
45. Wollmann CG, Bocker D, Loher A, Paul M, Scheld HH, Breithardt G, Gradaus R. Two different therapeutic strategies in ICD lead defects: additional combined lead versus replacement of the lead. J Cardiovasc Electrophysiol. 2007;18:1172-1177.
46. Wollmann CG, Bocker D, Loher A, Kobe J, Scheld HH, Breithardt GE, Gradaus R. Incidence of complications in patients with implantable cardioverter/ defibrillator who receive additional transvenous pace/sense leads. Pacing Clin Electrophysiol. 2005;28:795-800.
47. Suga C, Hayes DL, Hyberger LK, Lloyd MA. Is there an adverse outcome from abandoned pacing leads? J Interv Card Electrophysiol. 2000;4: 493-499.
48. Furman S, Behrens M, Andrews C, Klementowicz P. Retained pacemaker leads. J Thorac Cardiovasc Surg. 1987;94:770-772.
49. de Cock CC, Vinkers M, Van Campe LC, Verhorst PM, Visser CA. Long-term outcome of patients with multiple (≥3) noninfected transvenous leads: a clinical and echocardiographic study. Pacing Clin Electrophysiol. 2000;23:423-426.
50. Bohm A, Pinter A, Duray G, Lehoczky D, Dudas G, Tomcsanyi I, Preda I. Complications due to abandoned noninfected pacemaker leads. Pacing Clin Electrophysiol. 2001;24:1721-1724.
51. Parry G, Goudevenos J, Jameson S, Adams PC, Gold RG. Complications associated with retained pacemaker leads. Pacing Clin Electrophysiol. 1991;14:1251-1257.
52. Poole JE, Gleva MJ, Mela T, Chung M, Uslan D, Borge R, Gottipaty V, Shinn T, Dan D, Holcomb R. Complications associated with planned pacemaker or defibrillator lead addition at the time of generator change: results from the REPLACE registry. Abstract. Circulation. 2009;120:1.
53. Gleva MJ, Holcomb R, Mela T, Chung M, Borge R, Uslan D, Gottipaty V, Dan D, Shinn T, Poole J. Complication rates associated with pacemaker and implantable defibrillator generator replacement: results from the REPLACE registry. Heart Rhythm 30th Annual Scientific Sessions: Boston; 2009.
54. Robboy SJ, Harthorne JW, Leinbach RC, Sanders CA, Austen WG. Autopsy findings with permanent pervenous pacemakers. Circulation. 1969;39:495-501.
55. Huang TY, Baba N. Cardiac pathology of transvenous pacemakers. Am Heart J. 1972;83:469-474.
56. Smith MC, Love CJ. Extraction of transvenous pacing and ICD leads. Pacing Clin Electrophysiol. 2008;31:736-752.
57. Da Costa SS, Scalabrini Neto A, Costa R, Caldas JG, Martinelli Filho M. Incidence and risk factors of upper extremity deep vein lesions after permanent transvenous pacemaker implant: a 6-month follow-up prospective study. Pacing Clin Electrophysiol. 2002;25:1301-1306.
58. Korkeila P, Ylitalo A, Koistinen J, Airaksinen KE. Progression of venous pathology after pacemaker and cardioverter-defibrillator implantation: a prospective serial venographic study. Ann Med. 2009;41:216-223.
59. Haghjoo M, Nikoo MH, Fazelifar AF, Alizadeh A, Emkanjoo Z, Sadr-Ameli MA. Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade. Europace. 2007;9:328-332.
60. Bracke FA, Meijer A, Van Gelder LM. Symptomatic occlusion of the access vein after pacemaker or ICD lead extraction. Heart. 2003;89: 1348-1349.
61. Worley SJ. Implant venoplasty: dilation of subclavian and coronary veins to facilitate device implantation: indications, frequency, methods, and complications. J Cardiovasc Electrophysiol. 2008;19:1004-1007.
62. Ranjan R, Henrikson CA. ICD implantation after crossing a totally occluded subclavian vein via collaterals from the superior vena cava. Pacing Clin Electrophysiol. 2010;33:e14-e16.
63. Aleksic I, Kottenberg-Assenmacher E, Kienbaum P, Szabo AK, Sommer S-PP, Wieneke H, Yildirim C, Leyh RG. The innominate vein as alternative venous access for complicated implantable cardioverter defibrillator revisions. Pacing Clin Electrophysiol. 2007;30:957-960.
64. Bhakta M, Obioha CC, Sorajja D, Srivathsan K, Arabia FA, Devaleria PA, Jaroszewski DE, Scott LR, Altemose GT. Nontraditional implantable cardioverter defibrillator placement in adult patients with limited venous access: a case series. Pacing Clin Electrophysiol. 2010;33:217-225.
65. Antonelli D, Freedberg NA, Turgeman Y. Supraclavicular vein approach for upgrading an implantable cardioverter defibrillator to a biventricular device. Pacing Clin Electrophysiol. 2010;33:634-636.
66. Bluhm G. Pacemaker infections: a clinical study with special reference to prophylactic use of some isoxazolyl penicillins. Acta Med Scand Suppl. 1985;699:1-62.
67. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Stoner SM, Baddour LM. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis. 2007;45:166-173.
68. Nery PB, Fernandes R, Nair GM, Sumner GL, Ribas CS, Divakara Menon SM, Wang X, Krahn AD, Morillo CA, Connolly SJ, Healey JS. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. J Cardiovasc Electrophysiol. 2010; Jan 22. Epub ahead of print.
69. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med. 2000;133:604-608.
70. Baddour LM, Bettmann MA, Bolger AF, Epstein AE, Ferrieri P, Gerber MA, Gewitz MH, Jacobs AK, Levison ME, Newburger JW, Pallasch TJ, Wilson WR, Baltimore RS, Falace DA, Shulman ST, Tani LY, Taubert KA. Nonvalvular cardiovascular device-related infections. Circulation. 2003;108:2015-2031.
71. Samuels LE, Samuels FL, Kaufman MS, Morris RJ, Brockman SK. Management of infected implantable cardiac defibrillators. Ann Thorac Surg. 1997;64:1702-1706.
72. Tyers GF, Larrieu AJ, Nishimura A, Williams EH, Kurusz M, Brownlee RR. Suppression of a demand pacemaker in the presence of redundant transvenous right ventricular leads. Pacing Clin Electrophysiol. 1980;3: 84-87.
73. Widmann WD, Mangiola S, Lubow LA, Dolan FM. Suppression of demand pacemakers by inactive pacemaker electrodes. Circulation. 1972; 45:319-323.
74. Waxman HL, Lazzara R, El-Sherif N. Apparent malfunction of demand pacemakers due to spurious potentials generated by contact between two endocardial electrodes. Pacing Clin Electrophysiol. 1978;1:531-534.
75. Goudevenos JA, Reid PG, Adams PC, Holden MP, Williams DO. Pacemaker-induced superior vena cava syndrome: report of four cases and review of the literature. Pacing Clin Electrophysiol. 1989;12: 1890-1895.
76. Matthews DM, Forfar JC. Superior vena caval stenosis: a complication of transvenous endocardial pacing. Thorax. 1979;34:412-413.
77. Riley RF, Petersen SE, Ferguson JD, Bashir Y. Managing superior vena cava syndrome as a complication of pacemaker implantation: a pooled analysis of clinical practice. Pacing Clin Electrophysiol. 2010;33: 420-425.
78. Gilard M, Perennes A, Mansourati J, Etienne Y, Fatemi M, Blanc JJ, Boschat J. Stent implantation for the treatment of superior vena cava syndrome related to pacemaker leads. Europace. 2002;4:155-158.
79. Rossi A, Baravelli M, Cattaneo P, Romano M, Mariscalco G, Imperiale D, Rossi MC, Picozzi A, Dario P, Anza C, Montenero AS. Acute superior vena cava syndrome after insertion of implantable cardioverter defibrillator. J Interv Card Electrophysiol. 2008;23:247-249.
80. Melzer C, Lembcke A, Ziemer S, Eddicks S, Witte J, Baumann G, Borges AC. Pacemaker-induced superior vena cava syndrome: clinical evaluation of long-term follow-up. Pacing Clin Electrophysiol. 2006; 29:1346-1351.